3B BlackBio DX Intrinsic Value

3BBLACKBIO • Healthcare Services

3B BlackBio DX (3BBLACKBIO) median intrinsic value is ₹533.33 from 9 valuation models (range ₹301–₹1067), vs current price ₹1246.30 — -57.2% downside (Trading Above Calculated Value), margin of safety -100.0%. For current market price and key ratios, visit 3B BlackBio DX stock price NSE .

Current Stock Price
₹1246.30
Primary Intrinsic Value
₹842.40
Market Cap
₹1122 Cr
-57.2% Downside
Median Value
₹533.33
Value Range
₹301 - ₹1067
Assessment
Trading Above Calculated Value
Safety Margin
-100.0%

3BBLACKBIO Valuation Methods Summary — DCF, Graham Number & P/E

3B BlackBio DX intrinsic value across 9 models vs current price ₹1246.30 — upside/downside and value range per method. Browse 3BBLACKBIO cash flow statement for revenue, profit, balance sheet and cash flow data.

Method Type Intrinsic Value Range Upside/Downside Details
P/E Based Valuation earnings ₹842.40 ₹673.92 - ₹1010.88 -32.4% EPS: ₹70.20, Sector P/E: 12x
Book Value Method asset ₹301.11 ₹271.00 - ₹331.22 -75.8% Book Value/Share: ₹301.11, P/B: 1.0x
Revenue Multiple Method revenue ₹373.89 ₹336.50 - ₹411.28 -70.0% Revenue/Share: ₹173.33, P/S: 0.8x
EBITDA Multiple Method earnings ₹533.33 ₹480.00 - ₹586.66 -57.2% EBITDA: ₹80.00Cr, EV/EBITDA: 6x
Simple DCF (5Y) dcf ₹498.52 ₹398.82 - ₹598.22 -60.0% CF Growth: 5.0%, Discount: 15%
PEG Ratio Method growth ₹449.28 ₹404.35 - ₹494.21 -64.0% EPS Growth: 8.0%, Fair P/E: 6.4x
Growth Adjusted P/E growth ₹578.45 ₹520.61 - ₹636.30 -53.6% Revenue Growth: 6.0%, Adj P/E: 8.2x
ROE Based Valuation profitability ₹1066.67 ₹960.00 - ₹1173.34 -14.4% ROE: 22.1%, P/E Multiple: 16x
Graham Defensive Method conservative ₹602.22 ₹542.00 - ₹662.44 -51.7% EPS: ₹70.20, BVPS: ₹301.11
Method Types: Earnings Asset DCF Growth Dividend Conservative

3BBLACKBIO Intrinsic Value vs Market Price — All Valuation Models

3B BlackBio DX fair value range ₹301–₹1067 vs current market price ₹1246.30 across 9 valuation models. Compare with 3BBLACKBIO DCF to assess whether the stock is under or overvalued.

3BBLACKBIO Intrinsic Value Analysis — Undervalued or Overvalued?

3B BlackBio DX median intrinsic value ₹533.33, current price ₹1246.30 — Trading Above Calculated Value by 57.2%, margin of safety -100.0%.

What is the intrinsic value of 3BBLACKBIO?

Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of 3B BlackBio DX (3BBLACKBIO) is ₹533.33 (median value). With the current market price of ₹1246.30, this represents a -57.2% variance from our estimated fair value.

The valuation range spans from ₹301.11 to ₹1066.67, indicating ₹301.11 - ₹1066.67.

Is 3BBLACKBIO undervalued or overvalued?

Based on our multi-method analysis, 3B BlackBio DX (3BBLACKBIO) appears to be trading above calculated value by approximately 57.2%.

3BBLACKBIO Financial Health — Key Ratios vs Industry Benchmarks

3B BlackBio DX financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Current Ratio 22.00 Industry Standard: 2.0+ Above 2.0 Measures short-term liquidity capacity
Return on Equity 22.1% Industry Standard: 15%+ Above 15% Measures shareholder return efficiency
Operating Margin 43.0% Industry Standard: 20%+ Above 20% Indicates operational efficiency level
Asset Turnover Ratio 0.53x Industry Standard: 1.0x+ Above 0.5x Measures asset utilization efficiency

3BBLACKBIO Cash Flow Quality — Operating & Free Cash Flow

3B BlackBio DX operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2025 ₹43 Cr ₹26 Cr Positive Free Cash Flow 8/10
March 2024 ₹27 Cr ₹17 Cr Positive Free Cash Flow 8/10
March 2023 ₹20 Cr ₹20 Cr Positive Free Cash Flow 8/10
March 2022 ₹37 Cr ₹23 Cr Positive Free Cash Flow 8/10
March 2021 ₹98 Cr ₹63 Cr Positive Free Cash Flow 8/10